Clinical trials

Genomics
#Clinical trials #Drug discovery #Genetics / genomics #Multiomics

Designing multiomics studies to capture biological response

Dr Shi-qi An and Dr Naira Movsisyan of Novogene Europe consider why multiomics studies should follow biological responses over time, and how carefully chosen sampling points can distinguish initiating mechanisms from adaptation, compensation and the molecular signatures left by surviving cells.  In drug discovery, a compound is often assessed by what a biological system looks like… Read More

#Exclusive Content

UK
#Clinical trial design #Clinical trials #National Institute for Health and Care Research #UK

UK clinical trial set-up times drop significantly

Efforts by the National Institute for Health and Care Research (NIHR) have led to a fall in clinical research study set-up times, new UK government figures have revealed.  Data show that the time taken to set up commercial interventional clinical trials in the UK has fallen significantly,… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clinical research #Clinical trials #Data standardisation #Drug discovery

The evolution of AI agents in drug discovery

Partha Anbil and Satish Tadikonda explore the current state of AI agents in drug discovery, with a specific focus on clinical data harmonisation, the transition to autonomous laboratories, and the projected market growth that underscores this technological revolution.  Introduction: The dawn of agentic AI  Drug discovery is notoriously protracted, expensive, and fraught… Read More

#Exclusive Content

#Biotechnology #Cancer research #Clinical trials #Drug development #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (19-23 October)

News round-up for 19-23 October 2026 by Megan Thomas, Multimedia Editor at DDW.  In this week’s news roundup, drug discovery and biopharma companies continue to make progress across the drug development pipeline, with recent updates highlighting clinical trial milestones, emerging research and investment in new treatments. The… Read More

#News

Medicine concept
#Biomedical research #Clinical trials #Patient groups #Regulatory

Why patient access must keep pace for innovative medicines

Claus Zieler, Chief Commercial & Medical Affairs Officer, Astellas Pharma discusses the barriers preventing patients from accessing innovative medicines at the scale at which they’re being devleoped and approved.   Strong innovation, uneven access  Innovation in medicines is accelerating globally. In oncology, immunology, rare diseases, and other specialty areas, scientific advances are translating into more targeted and effective therapies… Read More

#Exclusive Content

CAR-T cell therapy
#Bristol Myers Squibb #CAR-T #Cell therapy #Clinical trials #Novartis

Novartis and BMS pause CAR-T trials due to safety concerns

Novartis and Bristol Myers Squibb (BMS) have both paused clinical trials of CAR-T cell therapies for lupus and other autoimmune diseases due to concerning safety findings.  Novartis has placed holds on trials of rapcabtagene autoleucel (rap-cel), stopping screening, randomisation, and treatment administration in trials in lupus, myasthenia… Read More

#News #Trending News

#Alcohol Use Disorder #Clinical trials #GLP-1 #Semaglutide #Wegovy #Weight loss

Weight-loss pill may quieten alcohol cravings

New research has shown that people taking oral semaglutide – the active ingredient used in Wegovy – experienced fewer heavy-drinking days, consumed fewer drinks when they did drink and reported weaker everyday cravings than those given a placebo. The eight-week randomised clinical trial involved 50 adults with moderate-to-severe alcohol use… Read More

#News

#Animal models #Clinical trials #Drug discovery #New approach methodologies (NAMs)

A turning point for human-based drug discovery

Daniel Delubac, Chief Executive Officer at iOrganBio looks at how technologies that mimic human behaviour can improve drug discovery efforts past animal models.   The US is signalling a decisive shift toward human-based drug discovery. In March, the National Institutes of Health (NIH) announced a $150 million investment to support the development of novel approaches that mimic human biology to reduce… Read More

#Exclusive Content

Cancer tumour
#Cancer vaccines #Clinical trials #Drug discovery #Oncology

Trial will assess precision therapeutic vaccine in oesophageal cancer 

Infinitopes has announced that the first patient has been dosed with ITOP1, the company’s lead investigational therapeutic cancer vaccine candidate.  This marks the first clinical evaluation of Infinitopes’ Precision Immunomics platform, which combines large-scale immunopeptidomic antigen discovery with engineered viral vector technologies, to identify naturally presented tumour antigens capable of generating durable anti-tumour T-cell responses. Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (10-14 August 2026) 

News round-up for 10-14 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new discoveries in cancer research, including the first trial of a new type of immunotherapy, an immune cell finding that could transform cancer treatment, and a groundbreaking drug… Read More

#News

Achondroplasia on ultrasound
#Ascendis Pharma #Clinical trials #Paediatrics

Ascendis provides update on achondroplasia programmes

Ascendis Pharma has provided updates across its achondroplasia programme, including data from the COACH and ApproaCH trials.  Combination therapy update  The company announced that treatment with the combination of once-weekly TransCon CNP and once-weekly TransCon hGH has continued to demonstrate durable growth in children with… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (3-7 August 2026) 

News round-up for 3-7 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new clinical trial results that demonstrate positive outcomes in Parkinson’s, colorectal cancer and Bundibugyo ebolavirus, as well as the first ever trial of a fridge-free vaccine. Elsewhere,… Read More

#News

#Biology #Clinical trials #Drug discovery #New approach methodologies (NAMs)

A turning point for human-based drug discovery 

Daniel Delubac, Chief Executive Officer at iOrganBio, looks at how technologies that mimic human behaviour can improve drug discovery efforts past animal models.  The US is signalling a decisive shift toward human-based drug discovery. In March, the National Institutes of Health (NIH) announced a $150 million investment to support the development of novel approaches that mimic human biology to reduce… Read More

#Exclusive Content

Breast cancer cell
#Breast cancer #Cancer therapeutics #Clinical trials #Intensity Therapeutics #intratumoural cancer therapies #Tumours

Phase II triple-negative breast cancer trial restarts

Intensity Therapeutics has administered INT230-6 in the INVINCIBLE-4 Study in Switzerland. The clinical biotechnology company is focused on the discovery and development of novel intratumoural cancer therapies that are designed to kill tumours and increase immune system recognition of cancers using its proprietary non-covalent conjugation technology. The trial (NCT06358573) analyses… Read More

#News

Cancer cells
#Cancer Research UK #Clinical trials #Oncology #Peptides

Cancer Research UK leads global trial of rare cancer therapy 

Cancer Research UK is leading a group of partners launching a global Phase II trial into rare adrenal gland cancer.  Biotechnology company Cytovation and the Norwegian Cancer Society (NCS) have joined forces with Cancer Research UK for the trial of people with advanced adrenocortical carcinoma (ACC), a rare and… Read More

#News #Trending News

#Clinical trials #Drug discovery #Life sciences

Why science parks will shape the next decade of scientific discovery 

By Angie Reynolds, Chief Operating Officer at University of Birmingham Enterprise and Board Director at the UK Science Park Association (UKSPA).  Birmingham Research Park is celebrating its 40th anniversary this year. Any milestone creates an opportunity to take stock about where you’ve come from and where you’re going – which seems timely given ongoing debates about what a difference location makes in an… Read More

#Exclusive Content